Atypical complex endometrial hyperplasia treated with the GyneLase system.
A 47-year-old premenopausal, para 1, gravida 1 woman complained of menometrorrhagia. She had no risk factors for endometrial hyperplasia or cancer, and office endometrial biopsy indicated focal, nonatypical endometrial hyperplasia. Seven months later the patient was scheduled for hysteroscopic endometrial resection. Instead she was treated by hysteroscopy, curettage, and the GyneLase system. The curetting indicated atypical, complex endometrial hyperplasia. The woman refused hysterectomy and salpingo-oophorectomy and adjunctive therapy with progesterone. She agreed to close surveillance and further treatment if she had any vaginal bleeding. At 13 months she remains amenorrheic, the endometrial echo is 2 mm, and follicle-stimulating hormone level is 63 IU/L. Based on the patient's amenorrhea and ultrasound uterine measurement, it is tempting to assume that GyneLase treatment may have cured her atypical hyperplasia. However, at this time, we have no evidence to substantiate this assumption.
Vilos
George A
GA
Department of Obstetrics and Gynecology, University of Western Ontario, London, Ontario, Canada.
Ettler
Helen C
HC
D003475:Curettage; D004714:Endometrial Hyperplasia / Q000473:pathology / Q000628:therapy*; D004717:Endometrium / Q000601:surgery*; D005260:Female; D006801:Humans; D015907:Hysteroscopy; D017075:Laser Coagulation / Q000295:instrumentation*; D008595:Menorrhagia / Q000601:surgery*; D008875:Middle Aged